Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine



Rating:

Share or cite this content

Citations should be made in the following way:
U. Costabel (Essen, Germany). Biomarkers in pulmonary fibrosis. Annual Congress 2011 - PG20 Biomarkers in respiratory medicine

Member's Comments

No comment yet.

Related content which might interest you: Developing pulmonary rehabilitation in interstitial lung disease Source: Annual Congress 2010 - PG22 Postgraduate Course: Developing pulmonary rehabilitation in non-COPD patients Year: 2010 Biomarkers in asthma and COPD Source: Annual Congress 2011 - PG20 Biomarkers in respiratory medicine Year: 2011 Smoking and pulmonary fibrosis Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Indicators of pulmonary exacerbation in adults with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: New aspects of diagnosis, inflammation and detecting exacerbation Year: 2011 Radiologic-pathologic correlations in interstitial lung disease Source: Annual Congress 2010 - PG16 ERS/ACCP jointly organised Postgraduate Course: Imaging and pathology of the lung Year: 2010 Interstitial lung disease Source: Annual Congress 2010 - Clinical reviews of the ERS's 20th Anniversary Year: asthma, lung cancer, interstitial lung disease and pulmonary hypertension Year: 2010 Novel biomarkers in bleomycin-induced pulmonary fibrosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease II Year: 2013 Oxidant/Antioxidant imbalance: a potential contributor to pulmonary fibrosis Source: Research Seminar 2010 - Novel insights in pulmonary fibrogenesis: from bench to bedside Research Seminar Year: 2010 Pulmonary vascular remodelling in pulmonary disease Source: Annual Congress 2011 - The burden of pulmonary hypertension in respiratory disease Year: 2011 Therapeutic update of severe pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Awake videothoracoscopic biopsy of diffuse lung disease. Effects on pulmonary function and oxygenation Source: Annual Congress 2010 - Vascular and haemodynamics Year: 2010 Consequences of chronic pulmonary TLR9 activation in the lung and beyond Source: Annual Congress 2011 - Translational models of airway disease Year: 2011 Pulmonary vascular injury, repair and remodelling in COPD patients Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Abnormal pulmonary arterial remodelling in patients with combined pulmonary fibrosis emphysema (CPFE) and idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2011 - Clinical approach of diffuse parenchymal lung disease Year: 2011 Serum KL-6 as a multidimensional biomarker in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016 Serum IGFBP2 as a marker of idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015